Roger Davenport Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Exits
  • 1


Roger Davenport General Information


Mr. Roger Davenport serves as Partner at QHP Capital. Mr. Davenport serves as Partner at NovaQuest Capital Management. He served as Chairman at Catalyst Clinical Research. He also serves as a Board Member at Clinical Ink and Pro-ficiency. Mr. Davenport served as Vice Chairman, Board of Trustees at East Carolina University. In this role, he was instrumental in the carve-out of the company from Intuit and returning its core portal solution to a market leadership position. Operationally, he created a culture where the company was awarded "Best Places to Work" by the Triangle Business Journal. In less than 12 months, the company developed and released two new products inpatient payments and consumer patient record integration leveraging both cloud and mobile technologies. Prior to Medfusion, Mr. Davenport was Chairman and CEO of Medquist, the leader in transcription services before and after the privatization of the company. As Chairman and CEO, Mr. Davenport facilitated a transformation of the business through the acquisition of a speech technology company, rebranding the company M*Modal and leading the take-private process that resulted in the sale of the business to One Equity Partners. Mr. Davenport's previous experience also includes his time as President, Allscripts; CEO, Misys Healthcare; GM & EVP, Kodak Health Group (now Carestream Health) and executive leadership roles at Siemens, Shared Medical Systems. Mr. Davenport started his career at IBM where he spent 11 years in sales, sales leadership and executive management positions. He also serves as a Board Member at Silvergate Pharmaceuticals and InformedDNA. He serves as Board Member at CoreRx. Mr. Davenport received an MBA from East Carolina University as well as a BSBA in Business.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 4509 Creedmoor Road
  • Suite 403
  • Raleigh, NC 27612
  • United States
+1 (919) 000-0000

Roger Davenport Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
myDrugCosts 09-May-2011 00000 00000 00000 Other Healthcare Technology Systems Generating Revenue 00000 000000000

Roger Davenport Exits (1)

Company Name Exit Date Exit Type Exit Size
myDrugCosts 01-Oct-2022 000000000 00000000

Roger Davenport Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Roger Davenport Team (1)

Name Title Deals Funds Boards Office
Roger Davenport Angel Investor 0 0 0 Raleigh, NC

Roger Davenport FAQs

  • Who is Roger Davenport?

    Roger Davenport is an angel Investor who has made 1 investment.

  • What kind of investor is Roger Davenport?

    Roger Davenport is an angel investor.

  • What does Roger Davenport do?

    As an angel investor, Roger Davenport invests personal money into promising companies, typically in exchange for equity.

  • What has Roger Davenport invested in?

    Roger Davenport has invested in myDrugCosts within the Healthcare Technology Systems industry.

  • What has Roger Davenport invested in recently?

    Roger Davenport's latest investment was on 09-May-2011 in myDrugCosts, a company within the Healthcare Technology Systems industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »